the aid library

LIST OPTIONS

Filter

13305

Download (948)

View PDF (1314)

Sexual and Reproductive Health of Women and Adolescent Girls Living With HIV

EngenderHealt;; UNFPA (2008)

guidance for health managers, health workers, and activists

External Link

Germanys expanding role in global health

Ilona Kickbusch, Christian Franz, Anna Holzscheiter, Iris Hunger, Albrecht Jahn, Carsten Kö; hler, Oliver Razum, Jean-Olivier Schmidt Lancet 2017; 390: 898– 912 (2017) CC

Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.

Download (365)

View PDF (631)

Policy brief: Disaster risk reduction and climate change

United Nations Office for Disaster Risk Reduction (UNDRR) (2021) C2

This policy brief explores the challenges faced in disaster risk governance in relation to the climate emergency.

Download (675)

View PDF (506)

Central Medical Stores Botswana 2010 – 2012 Strategic Plan

Thomson, D., Shivanandan, J. &; Brown, T. Ministry of Health, Botswana; PEPFAR; SCMS (2010)

Download (631)

View PDF (858)

Hazard definition and classification review

UN Office for Disaster Risk Reduction UNDRR (2020) C1

According to the International Science Council, the report focuses on identifying the scope of hazards that should be considered in risk reduction efforts, and provides scientifically robust and internationally agreed definitions of these hazards.

Download (287)

View PDF (284)

Measurement properties and interpretation of three shortened versions of the asthma control questionnaire

Juniper, E. F.; Svensson, K.; Mörk, A-C.; et al. Respiratory Medicine (2005) 99, 553–558 (2005) CC2

The Asthma Control Questionnaire (ACQ)1 was developed and validated to measure the primary clinical goal of asthma management as identified by international guidelines. They indicate that to achieve good control, treatment should minimise day and night time symptoms, activity limitation, airway narr... more

Download (468)

View PDF (671)

The Union's desk Guide für diagnosis and management of TB in children (Asia-Edition)

Stephen M. Graham USAID, l'Union, Initiative 5%; et. al (2016)

Third edition 2016

External Link

Zuhören hilft...

Refugio Villingen- Schwenningen Kontaktstelle f& amp; uuml& #59; r traumatisierte Fl& amp; uuml& #59; chtlinge e.V (2000) C1

Ratgeber für ehrenamtliche HelferInnen und DolmetscherInnen im Umgang mit von Krieg und Menschenrechtsverletzungen Betroffenen.

Download (546)

View PDF (385)

Etude Des Interactions Entre Les Differents Acteurs Des Interventions Sous Directives Communautaires Et Changements Obtenus Au Benin Et Au Togo

Malou Adom P. V.1, Makoutode Ch. P.2, Gnaro T.3, Ouro-Koura A.-R.4, Ouendo E. M.5, Napo-Koura G.6, Makoutode M.7 J. Rech. Sci. Univ. Lomé (Togo), Centre de Formation en Santé Publique (2016) C2

Introduction : Pour la mise en oeuvre des interventions sous directives communautaires, les Etats ont retenu le profil des agents de santé communautaire de même et le rôle et responsabilité que chaque acteur doit jouer. L’objectif du présent travail est d’étudier les interactions entre ... more

Download (1730)

View PDF (1827)

Maternal, Infant and Young Child Nutrition MIYCN Guidelines

Republic of South Sudan (2017) C1

Maternal, Infant and Young Child Nutrition Strategic Actions:
1 Endorse and disseminate key policies and regulations
2 Improve maternal nutrition
3 Protect, promote, and support optimal infant and young child feeding practices
4 Support optimal infant and young child feeding in ... more

Download (526)

View PDF (783)

How the marketing of formula milk influences our decisions on infant feeding

World Health Organization WHO (2022) CC

This report - the largest of its kind to date - draws on the experiences of over 8,500 women and 300 health professionals across eight countries. It exposes the aggressive marketing practices used by the formula milk industry, and highlights impacts on families’ decisions about how to feed their b... more

Download (550)

View PDF (650)

Policies to protect children from the harmful impact of food marketing: WHO guideline

World Health Organisation (WHO) (2023) C_WHO

Children continue to be exposed to powerful food marketing, which predominantly promotes foods high in saturated fatty acids, trans-fatty acids, free sugars and/or sodium and uses a wide variety of marketing strategies that are likely to appeal to children. Food marketing has a harmful impact on chi... more

Download (404)

View PDF (385)

Evidence Paper : no education, no protection

The Alliance for Child Protection in Humanitarian Action, Network for Education (2021) CC

What school closures under COVID-19 mean for children and young people in crisis-affected contexts

Download (745)

View PDF (1205)

Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus

World Health Organization WHO (2016)

Download (663)

View PDF (1106)

Fourth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus

World Health Organization WHO (2016)

Download (565)

View PDF (1315)

No Protection, No Respect

Safeguarding Health in Conflict Coalition (2016) CC

Health Workers and Health Facilities under Attack 2015, and Early 2016

Download (343)

View PDF (451)

Apostolisches Schreiben Evangelii Gaudiumdes

Papst Franziskus Vatikanesche Druckerei (2013) CC

Apostolisches Schreiben Evangelii Gaudium des Heiligen Vaters Papst Franziskus an die Bischöfe, an die Priester und Diakone, an die Personen geweihten Lebens und an die Christgläubigen Laien über die Verkündigung des Evangeliums in der Welt von heute

Download (589)

View PDF (785)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Achieving universal electrification of rural healthcare facilities in sub-Saharan Africa with decentralized renewable energy technologies

Moner-Girona, M.; et al. (2021) CC

Joule 5, 2687–2714 October 20, 2021 Cell Press

Download (1059)

View PDF (1118)

HIV Testing and Counselling (HTC) Plan, Malawi

Government of Malawi, Ministry of Health (2015) C1

The 5 years plan to scale up HIV Testing and Counselling Services in Malawi 2006-2010